Pharmexcil News Compilation Dt: 11.06.2010

PHARMACEUTICALS EXPORT PROMOTION COUNCIL
(Set up by Ministry of Commerce & Industry, Govt. of India)

Date: 11.06.2010

PHARMEXCIL NEWS COMPILATION- Dt: 11.06.2010

To
All the Members of Council

Dear Member,

Pharmexcil Compilation:

Date	Category	Subject	Source
11.06.2010	Alliance / Deals	Pharma tie-ups will lower prices	Hindu business Line
11.06.2010	Biologics	Pharmexcil raises concern over Sri Lankas new approval procedure for bio-similars	Pharmabiz
11.06.2010	Merger / Acquisition	Orchid to acquire Karalex to boost its US portfolio	Financial Express
11.06.2010	Merger / Acquisition	Sanofi in I-T net, told to pay Rs 650 cr over Shantha buy	Economic Times
11.06.2010	Merger / Acquisition	Chinese drug firm readies for Pfizer unit takeover	iStockAnalyst
11.06.2010	Quality Standards	Pfizer recalls 3 drugs made by Indian pharma company	Financial Express
11.06.2010	General	Ranbaxy brings Prasugrel to India	Financial Express
11.06.2010	Government	DoP now plans pharma park for North-East region, NIPER Guwahati completed	Pharmabiz
11.06.2010	Government	Health ministry finalizes ART Bill, to be introduced in Parliament soon	Pharmabiz
11.06.2010	IPR / International	Study finds US supports innovation better than EU	Pharmajobs
11.06.2010	Merger / Acquisition	Cardinal acquisition highlights growing specialty drug market	FiercePharma
11.06.2010	International Market	Drug spending in U.S., Canada about same: report	CBC News

Previous news Please CLICK HERE

Other Pharma Related News

Date	Category	Subject	Source
11.06.2010	General	Bristol-Myers to price drugs lower for Indian market	Hindu business Line

We invite Suggestion / feedback from members about Pharma News Compilation Service - Feedback

Pharmexcil also invites all interested Pharma Executives to register for daily news compilation – Free Registration

Regards,

Dr.P.V.Appaji
Executive Director

Disclaimer: Pharmexcil has been preparing this daily news compilation as a service to its members. The council has been including such news items as it considers useful to the best of its judgment. Pharmexcil therefore is not responsible for any omissions or commissions of news items.